Paul Luong, OD
Optometrist · Saint Louis, MONPI 1992155923
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $29,051 of the $44,123 with a category attached, or 65.8%. Bausch & Lomb Americas Inc. accounts for 75.0% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2023 at $13,583 and has fallen 57.9% since, to $5,721 in 2025. Among optometrist clinicians in MO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 163 payments — averaging $270.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$33K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$10K
- Johnson & Johnson Vision Care, Inc.$746
- Coopervision Inc.$207
- ABB Con-cise Optical Group LLC$108
- AbbVie$72
- plus $96 from 4 others
What the payments were for
- Consulting fees$3,8759%
- Speaking & faculty fees$29,05166%
- Travel & lodging$6,20514%
- Food & beverage$4,99211%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 98 | $33,109 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 28 | $9,785 |
| Johnson & Johnson Vision Care, Inc. | 23 | $746 |
| Coopervision Inc. | 4 | $207 |
| ABB Con-cise Optical Group LLC | 5 | $108 |
| AbbVie | 1 | $72 |
| Sun Pharmaceutical Industries Inc. | 1 | $34 |
| Rxsight Inc | 1 | $26 |
| Glaukos Corporation | 1 | $24 |
| Alcon | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INFUSE$29,450
- INFUSE MULTIFOCAL$7,010
- ULTRA$2,951
- BIOTRUE ONE DAY$2,951
- ULTRA MULTIFOCAL TORIC$2,000
- SOFLENS$250
- Acuvue$124
How this compares
$44,123 in reported general payments places this provider in the 95th percentile of 1,030 optometrist providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 12 | $461 |
| Latanoprost | 55 | $427 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 33 | $282 |
| Dorzolamide Hcl | 12 | $230 |
Paid to pharmacies, not to this prescriber.
Other optometrist in Saint Louis
- John McGrealSaint Louis$126K
- Ariel CerenzieSaint Louis$76K
- Robert EnsleySaint Louis$38K
- Andrew RoyerSaint Louis$23K
- Robert BrusattiSaint Louis$20K
- Edward BennettSaint Louis$13K
- Craig SorceSaint Louis$8K
- Julie DekinderSaint Louis$8K
- Erin SullivanSaint Louis$6K
- Kathryn NoonanSaint Louis$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.